Reviews Write New Review
[email protected]
Michael Rosenblatt
Chief Medical Officer, MERCK.
Scientist, academic, hospital and global healthcare company executive, Michael Rosenblatt, M.D., is executive vice president and chief medical officer at Merck. He is the company’s primary external advocate on medical issues and the independent voice of the patient inside Merck.
Dr. Rosenblatt previously was Dean of Tufts University School of Medicine; the George R. Minot Professor of Medicine at Harvard Medical School, and president of Beth Israel Deaconess Medical Center (BIDMC). He was the Harvard faculty dean and senior vice president for academic programs at CareGroup and BIDMC. He was also director of the Harvard-MIT Division of Health Sciences and Technology.
Prior to these leadership positions, he was senior vice president for research at Merck where he co-led the worldwide development team for alendronate (FOSAMAX®). Earlier, he was chief of the Endocrine Unit at the Massachusetts General Hospital.
Committed to innovation, he has served on the board of directors and scientific advisory boards of several biotechnology companies and was a scientific founder of ProScript and Radius Pharmaceuticals.
Dr. Rosenblatt was elected to the American Society of Clinical Investigation and the Association of American Physicians, is a fellow of the American Association for the Advancement of Science and the American College of Physicians, and served as the president of the American Society of Bone and Mineral Research.
He received his undergraduate degree summa cum laude from Columbia University and his M.D. magna cum laude from Harvard Medical School.
Related Speakers View all
Dr. Mehmet Oz
Cardiothoracic Surgeon; Host of "The Dr. Oz Show;" C...
|
|
Vikram Patel
The Pershing Square Professor of Global Health at Ha...
|
|
Dean Kamen
Founder of FIRST; President of DEKA Research & Devel...
|
|
Dr. Joel Selanikio
Award-Winning Physician, Health & Technology Activis...
|
|
Robert A. Winn
Director & Lipman Chair in Oncology at the Virginia ...
|
|
Shekinah Elmore
Oncologist; Dedicated to Pursuing Equity & Empathy i...
|
|
Richie Etwaru
Chief AI Officer, Serial Artificial Intelligence Inv...
|
|
Susannah Fox
Health & Technology Strategist, Author of "Rebel Hea...
|
|
Tal Golesworthy
Tal Golesworthy is an engineer and entrepreneur, wor...
|
|
Bart Knols
Scientist, Author, Entrepreneur
|
|
Giovanni Colella
Co-Founder & CEO at Castlight Health
|
|
Vic Strecher, Ph.D. MPH
Founder, JOOL Health; Professor, University of Michi...
|
|
Dr. John Wynn
Medical Director for Cancer Psychiatry at the Swedis...
|
|
Eric Schadt
Director, Institute of Genomics and Multiscale Biolo...
|
|
Jonathan Bush
Technology Entrepreneur; Co-Founder & Former CEO of ...
|
|
Keller Rinaudo
Co-founder and CEO of Zipline
|
|
Rudolph E. Tanzi
Alzheimer's Disease Researcher; Expert on the Geneti...
|
|
Dave deBronkart
Kidney Cancer Survivor & Patient Advocate Known as "...
|
|
Deepak Chopra
Co-Founder of The Chopra Center for Wellbeing
|
|
Farzad Mostashari, M.D.
Founder & CEO of Aledade, Inc. & Former National Coo...
|